Pune: Serum Institute To File Rs 100 Crore Defamation Suit Against Chennai COVID Vaccine Volunteer

Adar Poonawalla
Share this News:

Pune, November 29, 2020: Serum Institute of India (SII) has said that allegations by a Chennai volunteer about the COVID vaccine are ‘malicious’.

“The allegations in the notice are malicious and misconceived. While the Serum Institute of India is sympathetic with the volunteer’s medical condition, there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer. The volunteer is falsely laying the blame for his medial problems on the COVID vaccine trial.

The claim is malicious because the volunteer was specifically informed by the medical team that the complications he suffered were independent of the vaccine trial he underwent. In-spite of specifically being made aware of the same, he still chose to go public and malign the reputation of the company.

It is evident that the intention behind the spreading of such malicious information is an oblique pecuniary motive. The Serum Institute of India, will seek damages in excess of 100 crore for the same and will defend such malicious claims”, SII said in statement.

Earlier the 40-year-old business consultant from Chennai, who was a volunteer for the Covidshield vaccine, had issued a legal notice to SII, AstraZeneca, Oxford University among others, and sought Rs five crore compensation for the neurological complications he developed after being administered the test dose.